Screener
Pulse Biosciences, Inc. PLSE Total Revenue
Discontinued — last reported Q2 '26
Total Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue | $434 | — | $835 | — |
| Cost and expenses: | ||||
| Cost of product revenue | 273 | — | 643 | — |
| Research and development | 16,976 | 12,088 | 29,566 | 22,401 |
| Selling, general and administrative | 8,457 | 8,187 | 15,048 | 15,918 |
| Total cost and expenses | 25,706 | 20,275 | 45,257 | 38,319 |
| Loss from operations | (25,272) | (20,275) | (44,422) | (38,319) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s total revenue?
- Pulse Biosciences, Inc. (PLSE) reported total revenue of $434K in Q2 2026.
- What is the long-term trend for Pulse Biosciences, Inc.'s total revenue?
- Over 3 years (2022 to 2025), Pulse Biosciences, Inc.'s total revenue has grown at a -21.0% compound annual growth rate (CAGR), from $709K to $350K.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Pulse Biosciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude